Live Chat ×
Skip to main content

Independent Study with an Expert: WHO’s in Bone



Original release date:
December 3, 2020
Access to this course expires on: June 3, 2021 at 11:59 PM Pacific Time
CME 1.25

Course Description
The fifth edition of the World Health Organization Classification of Tumors of Soft Tissue and Bone was published in early 2020. The revisions reflect a consensus among an international expert editorial board composed of bone and soft tissue pathologists, molecular pathologists, a medical oncologist, surgeons, and radiologists. The changes in the bone chapter notably include reclassification of some tumors, deleted entities, and the inclusion of new entities. This lecture will discuss the significant changes and explain in some detail the concept of atypical cartilaginous tumor, which has caused some confusion since first introduced.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Be aware of the current changes in the WHO classification of bone tumors.
  • Understand the concept of atypical cartilaginous tumor (ACT) and how it should be used.

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: G. Petur Nielsen, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.